PRAXIS PRECISION MEDICINES, INC. Other Accrued Liabilities, Current
PRAXIS PRECISION MEDICINES, INC. (PRAX) had Other Accrued Liabilities, Current of $1.95 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Other Accrued Liabilities, Current $1.95M.
- 2026-03-31: Other Accrued Liabilities, Current $1.72M.
- 2025-12-31: Other Accrued Liabilities, Current $2.03M.
- 2025-09-30: Other Accrued Liabilities, Current $2.32M.
| Period end | Other Accrued Liabilities, Current | Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.95M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $1.72M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $2.03M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $2.32M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $1.11M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $1.76M 10-Q · filed 2025-05-02 | |
| 2024-12-31 | $1.03M 10-K · filed 2026-02-19 | |
| 2024-09-30 | $539.00K 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $641.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $598.00K 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $743.00K 10-K · filed 2025-02-28 | |
| 2023-09-30 | $611.00K 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $791.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $1.25M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $2.31M 10-K · filed 2024-03-05 | |
| 2022-09-30 | $2.26M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $3.28M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $2.50M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $1.90M 10-K · filed 2023-02-07 | $362.00K 10-K · filed 2022-02-28 |
| 2021-09-30 | $948.00K 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $799.00K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $742.00K 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $1.01M 10-K · filed 2022-02-28 | $1.15M 10-K · filed 2021-03-17 |
| 2020-09-30 | $75.00K 10-Q · filed 2020-11-23 | |
| 2019-12-31 | $481.00K 10-K · filed 2021-03-17 | $371.00K 10-Q · filed 2020-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |